Use-dependent potentiation of voltage-gated calcium channels rescues neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A
Abstract Botulinum neurotoxins (BoNTs) are highly potent toxins that cleave neuronal SNARE proteins required for neurotransmission, causing flaccid paralysis and death by asphyxiation. Currently, there are no clinical treatments to delay or reverse BoNT-induced blockade of neuromuscular transmission...
Guardado en:
Autores principales: | Phillip H. Beske, Katie M. Hoffman, James B. Machamer, Margaret R. Eisen, Patrick M. McNutt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96fff58717034b729ab96d902fc0e129 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recombinant botulinum neurotoxin serotype A1 in vivo characterization
por: Cindy Périer, et al.
Publicado: (2021) -
On Botulinum Neurotoxin Variability
por: Cesare Montecucco, et al.
Publicado: (2015) -
Identification and characterization of a novel botulinum neurotoxin
por: Sicai Zhang, et al.
Publicado: (2017) -
Neurologic uses of botulinum neurotoxin type A
por: John P Ney, et al.
Publicado: (2007) -
Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A).
por: Birgitte P S Jacky, et al.
Publicado: (2013)